Evolución adicional hacia una terapia efectiva para el ictus isquémico agudo agudo
Video Experimental Relacionado
Updated: Oct 29, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
1Department of Neurology, Memorial Health Care, University of Massachusetts Medical School, Worcester 01605, USA. fisherm@memorialhc.org
JAMA
|May 2, 1998
Resumen
El tratamiento eficaz del ictus isquémico agudo está avanzando. El activador de plasminógeno de tipo tisular se aprueba en 3 horas, mientras que los fármacos neuroprotectores son prometedores para futuras terapias combinadas para maximizar la recuperación.
Área de la Ciencia:
- Neurología Neurología.
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Farmacología Farmacología.
Sus antecedentes:
- El tratamiento del accidente cerebrovascular isquémico agudo es un objetivo médico crítico con avances en curso.
- La terapia trombolítica ha surgido como una estrategia de tratamiento clave para pacientes específicos de accidente cerebrovascular.
Objetivo del estudio:
- Revisar el panorama actual de los tratamientos para el ictus isquémico agudo.
- Para discutir la eficacia y las limitaciones de las terapias existentes y las direcciones futuras.
Principales métodos:
- Revisión de ensayos clínicos recientes y aprobaciones terapéuticas para el ictus isquémico agudo.
- Análisis de la eficacia y los perfiles de seguridad de los agentes trombolíticos y las intervenciones neuroprotectoras.
Principales resultados:
- El activador de plasminógeno de tipo tisular (tPA) está aprobado para el accidente cerebrovascular isquémico agudo dentro de las 3 horas de inicio.
- La estreptokinasa no es efectiva y aumenta el riesgo de hemorragia; su uso temprano no se evaluó.
- Los agentes neuroprotectores efectivos en modelos animales aún no han demostrado ser exitosos en ensayos en humanos.
Conclusiones:
- El futuro tratamiento del accidente cerebrovascular isquémico agudo puede incluir terapia combinada con trombolíticos y neuroprotectores.
- La selección cuidadosa del paciente y el tiempo de tratamiento son cruciales para maximizar el potencial de recuperación con las terapias combinadas.
Videos de Conceptos Relacionados
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...